Amylyx Pharmaceuticals, Inc. SEC filings AMLX

Amylyx Pharmaceuticals, Inc. has 440 filings in SEC EDGAR's recent list, going back to Nov 17, 2015. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Amylyx Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
4 Insider transaction Oct 7, 2026 Oct 5, 2026
144 Notice of proposed sale Oct 5, 2026 —
4 Insider transaction Sep 14, 2026 Sep 10, 2026
4 Insider transaction Sep 14, 2026 Sep 10, 2026
4 Insider transaction Sep 14, 2026 Sep 10, 2026
4 Insider transaction Sep 14, 2026 Sep 10, 2026
4 Insider transaction Sep 14, 2026 Sep 10, 2026
144 Notice of proposed sale Sep 11, 2026 —
144 Notice of proposed sale Sep 11, 2026 —
144 Notice of proposed sale Sep 11, 2026 —
144 Notice of proposed sale Sep 11, 2026 —
144 Notice of proposed sale Sep 11, 2026 —
8-K Current report
Material agreement
Sep 8, 2026 Sep 1, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Aug 20, 2026 Aug 18, 2026
4 Insider transaction Aug 20, 2026 Aug 18, 2026
4 Insider transaction Aug 20, 2026 Aug 18, 2026
4 Insider transaction Aug 20, 2026 Aug 18, 2026
4 Insider transaction Aug 20, 2026 Aug 18, 2026
8-K Current report
Material agreement
Aug 20, 2026 Aug 19, 2026
424B5 Prospectus supplement Aug 20, 2026 —
424B5 Prospectus supplement Aug 18, 2026 —
8-K Current report
Other events
Aug 18, 2026 Aug 18, 2026
8-K Current report
Regulation FD disclosure, Other events
Aug 18, 2026 Aug 18, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
4 Insider transaction Jul 13, 2026 Jul 9, 2026
144 Notice of proposed sale Jul 9, 2026 —
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
8-K Current report
Shareholder vote results
Jun 4, 2026 Jun 4, 2026
4 Insider transaction May 26, 2026 May 21, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
ARS Annual report to shareholders Apr 23, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 23, 2026 —
DEF 14A Proxy statement Apr 23, 2026 Jun 4, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
8-K Current report
Regulation FD disclosure
Mar 24, 2026 Mar 24, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
S-8 Employee stock plan registration Mar 3, 2026 —
S-3ASR Automatic shelf registration Mar 3, 2026 —
10-K Annual report Mar 3, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 3, 2026 Mar 3, 2026
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
4 Insider transaction Feb 25, 2026 Feb 23, 2026
144 Notice of proposed sale Feb 23, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2026 —
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
144 Notice of proposed sale Feb 2, 2026 —
144 Notice of proposed sale Feb 2, 2026 —
144 Notice of proposed sale Feb 2, 2026 —
144 Notice of proposed sale Feb 2, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jan 30, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 21, 2026 —
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
144 Notice of proposed sale Jan 16, 2026 —
144 Notice of proposed sale Jan 16, 2026 —
144 Notice of proposed sale Jan 15, 2026 —
144 Notice of proposed sale Jan 15, 2026 —
4 Insider transaction Jan 14, 2026 Jan 12, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
8-K Current report
Regulation FD disclosure, Other events
Jan 8, 2026 Jan 8, 2026
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
4 Insider transaction Dec 23, 2025 Dec 23, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
144 Notice of proposed sale Dec 1, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 17, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 13, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 30, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Oct 7, 2025 —
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
8-K Current report
Material agreement
Sep 10, 2025 Sep 9, 2025
424B5 Prospectus supplement Sep 10, 2025 —
424B5 Prospectus supplement Sep 9, 2025 —
8-K Current report
Other events
Aug 27, 2025 Aug 27, 2025
4 Insider transaction Aug 14, 2025 Aug 12, 2025
144 Notice of proposed sale Aug 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 12, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
SCHEDULE 13G Ownership over 5% (passive) Jul 29, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jul 17, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jun 25, 2025 —
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
8-K Current report
Shareholder vote results
Jun 5, 2025 Jun 5, 2025
4 Insider transaction May 27, 2025 May 22, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 12, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
ARS Annual report to shareholders Apr 24, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 24, 2025 —
DEF 14A Proxy statement Apr 24, 2025 Jun 5, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
EFFECT Filing Mar 26, 2025 —
CORRESP Letter to the SEC Mar 24, 2025 —
4 Insider transaction Mar 24, 2025 Mar 20, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
UPLOAD Letter from the SEC Mar 5, 2025 —
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
S-8 Employee stock plan registration Mar 4, 2025 —
S-3 Shelf registration Mar 4, 2025 —
10-K Annual report Mar 4, 2025 Dec 31, 2024
POSASR Filing Mar 4, 2025 —
8-K Current report
Results of operations
Mar 4, 2025 Mar 4, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Feb 6, 2025 Feb 5, 2025
4 Insider transaction Feb 5, 2025 Feb 3, 2025
4 Insider transaction Feb 5, 2025 Feb 3, 2025
4 Insider transaction Feb 5, 2025 Feb 3, 2025
4 Insider transaction Jan 28, 2025 Jan 24, 2025
SCHEDULE 13G Ownership over 5% (passive) Jan 14, 2025 —
8-K Current report
Material agreement
Jan 10, 2025 Jan 10, 2025
424B5 Prospectus supplement Jan 10, 2025 —
424B5 Prospectus supplement Jan 10, 2025 —
4 Insider transaction Jan 8, 2025 Jan 6, 2025
4 Insider transaction Jan 8, 2025 Jan 6, 2025
8-K Current report
Regulation FD disclosure
Dec 30, 2024 Dec 30, 2024
4 Insider transaction Dec 3, 2024 Dec 2, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
4 Insider transaction Nov 6, 2024 Nov 4, 2024
SC 13G Ownership over 5% (passive) Nov 4, 2024 —
SC 13G Ownership over 5% (passive) Oct 25, 2024 —
8-K Current report
Other events
Oct 17, 2024 Oct 17, 2024
4 Insider transaction Oct 2, 2024 Sep 30, 2024
4 Insider transaction Oct 2, 2024 Sep 30, 2024
4 Insider transaction Oct 2, 2024 Sep 30, 2024
4 Insider transaction Oct 2, 2024 Sep 30, 2024
4 Insider transaction Sep 25, 2024 Sep 23, 2024
4 Insider transaction Sep 16, 2024 Sep 12, 2024
4 Insider transaction Sep 16, 2024 Sep 12, 2024
4 Insider transaction Sep 9, 2024 Sep 5, 2024
4/A Filing Sep 5, 2024 Aug 23, 2023
4 Insider transaction Sep 5, 2024 Sep 3, 2024
SC 13G Ownership over 5% (passive) Aug 26, 2024 —
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Acquisition or sale of assets
Jul 10, 2024 Jul 9, 2024
SC 13G/A Amended ownership over 5% (passive) Jul 8, 2024 —
8-K Current report
Material agreement
Jun 21, 2024 Jun 21, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
AMLX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cambridge, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1658551

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.